Amrize stock price target lowered to $54 by RBC Capital on guidance concerns

Published 08/08/2025, 14:56
Amrize stock price target lowered to $54 by RBC Capital on guidance concerns

Investing.com - RBC Capital lowered its price target on Amrize Ltd (NYSE:AMRZ) to $54.00 from $61.00 on Friday, while maintaining an Outperform rating on the stock. The stock currently trades at $46.72, having declined 8.55% in the past week, according to InvestingPro data.

The price target reduction follows what RBC described as "share price weakness" that the firm believes "could have been avoided" if Amrize had been more proactive in its communications with investors.

According to RBC Capital, Amrize "passed on the opportunity to lead the narrative and to guide consensus" ahead of its second-quarter results and fiscal year 2025 estimates.

The investment bank noted that investors currently believe Amrize missed its Q2 guidance and reduced its FY2025 outlook, creating what RBC called a "’he said, she said’ situation."

Despite the price target cut, RBC maintained its Outperform rating, suggesting the current situation "may lead investors to miss out on an attractive entry point in the Amrize story."

In other recent news, Amrize has partnered with Meta (NASDAQ:META) to develop an AI-optimized concrete mix for Meta’s data center in Rosemount, Minnesota. This collaboration aims to deliver a high-strength concrete solution while reducing the carbon footprint by an estimated 35%. JPMorgan has initiated coverage on Amrize with an Overweight rating, highlighting the company’s structure, which includes Building Materials and Building Envelope segments. Bernstein also started coverage with an Outperform rating, emphasizing Amrize’s strong position in inland markets and its pricing power. Goldman Sachs initiated coverage with a Neutral rating, noting Amrize’s leading position in the North American cement market with a 23% revenue share. Furthermore, Berenberg has given Amrize a Buy rating, citing a robust mid-term profit outlook with projected average EBITDA growth of 8% per year. These recent developments reflect Amrize’s strategic positioning and growth prospects in the industry.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.